IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

Announcement: Multiple Sclerosis Conference

Cambridge Healthtech Institute inquiries at healthtech.com
Wed Nov 22 15:36:48 EST 1995

Cambridge Healthtech Institute, producer of meetings of interest to
biomedical professionals, is announcing their upcoming meeting,
"Prevention and Treatment of Multiple Sclerosis:The New Autoimmunity
Model" to be held: April 1-2, 1996 in Atlanta, Georgia.

Conference Overview:
Development of an Infrastructure Suitable for Highthroughput
Genotyping:  Dr. Richard McIndoe, University of  Washington 
Genetics of MS: Dr. G.C. Ebers, University of Western Ontario
Potential of Viruses to Trigger MS: Dr. Kai Wucherpfennig, Dana Farber
Link between Herpes and Pathogenesis of MS: Dr. Richard Garber,

Panel on Recombinant interferon beta
Dr. John Alam, Biogen
Dr. Ayad Abdul-Ahad, Ares-Serono 

TNF Receptors for Treatment of MS: 
	Dr. David Martin, Amgen
Use of Thalidomide to Suppress Tumor Necrosis Factor in MS:  
	Dr. Lawrence W. Myers, UCLA
Matrix Metalloprotease Inhibitors for Treatment of MS: 
	Dr. Koenraad Gijbels,  Stanford

Developement of Altered Peptide Ligand Therapy for MS: 
	Dr. Paul Conlon, Neurocrine Biosciences
T Cell Receptor Peptide Vaccine as an Immunotherapy for MS:  
	Dr. Steven Brostoff, Immune Response
T Cell Receptor Peptide-Based Vaccine for MS: 
	Dr. Edward Amento, Connective Therapeutics 
Treatment of Multiple Sclerosis by Soluble MHC II-Peptide Complexes:

	Dr. Bishwajit Nag, Anergen, Inc. 
Treatment of Multi-component Murine EAE by One T-cell Reactive
	Dr. Barbara Wallner, ImmuLogic  

Development of Apogens for Treatment of MS: 
	Dr. John Mueller, Alexion 
CD4-derived Peptides & Peptidomimetics as Inhibitors of MS: 
	Dr. Ziwei Huang, Jefferson Medical College 
Oral Tolerance Therapy in MS: Dr. Robert Bishop, AutoImmune
Development of T Cell Receptor Specific Monoclonal Antibody Therapy
for MS:  
	Dr. Carl 	Harald Janson, Astra Arcus (Sweden) 
Copaxone:Clinical Efficacy and Safety in Relapsing-Remitting MS
	Dr. Ben Zion Weiner, Teva 

For more information on this meeting contact Cambridge Healthtech
Institute.  Please include your full mailing address and fax number
(if applicable).
Cambridge Healthtech Institute      
1037 Chestnut Street
Newton Upper Falls, MA  02164
tel: 617.630.1300
fax: 617.630.1325
inquiries at healthtech.com
World Wide Web http://www.healthtech.com/conferences

More information about the Neur-sci mailing list

Send comments to us at biosci-help [At] net.bio.net